Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Claritev (CTEV) Asset Writedowns and Impairment (2022 - 2024)

Claritev has reported Asset Writedowns and Impairment over the past 2 years, most recently at $54.5 million for Q4 2024.

For Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to $54.5 million; the TTM value through Sep 2025 reached $54.5 million, down 96.2%, while the annual FY2024 figure was $1.5 billion, N/A changed from the prior year.
Asset Writedowns and Impairment for Q4 2024 was $54.5 million at Claritev, down from $361.6 million in the prior quarter.
Over five years, Asset Writedowns and Impairment peaked at $660.3 million in Q4 2022 and troughed at $54.5 million in Q4 2024.